Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Guoxia Jin"'
Publikováno v:
Inorganic Chemistry. 62:6544-6548
Autor:
Xinhui Chen, Fan Yang, Congcong Han, Licong Han, Fubo Wang, Guoxia Jin, Haiying Wang, Jianping Ma
Publikováno v:
Inorganic Chemistry. 61:13261-13265
Autor:
Xinhui, Chen, Fan, Yang, Congcong, Han, Licong, Han, Fubo, Wang, Guoxia, Jin, Haiying, Wang, Jianping, Ma
Publikováno v:
Inorganic chemistry. 61(34)
Three [Fe
Publikováno v:
Journal of Colloid and Interface Science. 587:358-366
Chemodynamic therapy (CDT) utilizes Fenton catalysts to convert intracellular hydrogen peroxide (H2O2) into cytotoxic hydroxyl radical (OH∙) for tumor therapy, but endogenous H2O2 is usually insufficient to achieve satisfactory tumor therapy effect
Publikováno v:
ACS Infectious Diseases. 6:2181-2191
Pneumolysin (Ply), pneumococcal surface protein A (PspA), and pneumococcal surface adhesin A (PsaA) are promising cell surface protein antigen targets for Streptococcus pneumoniae (Spn) vaccine development. Herein, we designed and recombined two fusi
Publikováno v:
RSC Advances. 10:30110-30114
Glucose-1-phosphate thymidylyltransferase (Cps23FL) from Streptococcus pneumonia serotype 23F is the initial enzyme that catalyses the thymidylyl transfer reaction in prokaryotic deoxythymidine diphosphate-L-rhamnose (dTDP-Rha) biosynthetic pathway.
Publikováno v:
Journal of Molecular Liquids. 274:556-561
A prodrug-participating catanionic system was developed for effective delivery of the chemotherapeutic agent chlorambucil (CLB). The catanionic aggregates were easily formed by mixing as-synthesized cationic CLB prodrug, N-(2-amino-ethyl)-4-{4-[bis-(
Publikováno v:
Organic & Biomolecular Chemistry. 17:1071-1075
A new β-rhamnoslytransferase Cps23FT from Streptococcus pneumonia serotype 23F was expressed and characterized. Its enzymatic activity and function were confirmed for the first time by utilizing enzymatically prepared dTDP-Rha and chemically synthes
Publikováno v:
Acta biomaterialia. 124
Arginase 1 (ARG1) inactivates T cells by degrading L-arginine, severely reducing the immunotherapeutic efficacy. Effectively blocking the ARG1 pathway remains a challenge. L-norvaline is a very cheap and negligible side effects inhibitor of ARG1. How
Publikováno v:
ACS infectious diseases. 6(8)
Pneumolysin (Ply), pneumococcal surface protein A (PspA), and pneumococcal surface adhesin A (PsaA) are promising cell surface protein antigen targets for